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Abstract
Intestinal luminal microbiota likely contribute to the etiology of necrotizing enterocolitis (NEC), a common disease in
preterm infants. Microbiota development, a cascade of initial colonization events leading to the establishment of a diverse
commensal microbiota, can now be studied in preterm infants using powerful molecular tools. Starting with the first stool
and continuing until discharge, weekly stool specimens were collected prospectively from infants with gestational ages #32
completed weeks or birth weights#1250 g. High throughput 16S rRNA sequencing was used to compare the diversity of
microbiota and the prevalence of specific bacterial signatures in nine NEC infants and in nine matched controls. After
removal of short and low quality reads we retained a total of 110,021 sequences. Microbiota composition differed in the
matched samples collected 1 week but not ,72 hours prior to NEC diagnosis. We detected a bloom (34% increase) of
Proteobacteria and a decrease (32%) in Firmicutes in NEC cases between the 1 week and ,72 hour samples. No significant
change was identified in the controls. At both time points, molecular signatures were identified that were increased in NEC
cases. One of the bacterial signatures detected more frequently in NEC cases (p,0.01) matched closest to c-Proteobacteria.
Although this sequence grouped to the well-studied Enterobacteriaceae family, it did not match any sequence in Genbank
by more than 97%. Our observations suggest that abnormal patterns of microbiota and potentially a novel pathogen
contribute to the etiology of NEC.
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Introduction
Necrotizing enterocolitis (NEC) is a devastating disease with a
multi-factorial etiology that affects primarily premature infants
and carries a huge burden in terms of mortality, morbidity, and
cost to society.[1] One hypothesis suggests that a major etiological
factor for NEC is colonization of the neonatal gut with an
abnormal microbiota,[2] particularly as NEC typically occurs after
days 8–10 d postpartum when anerobic bacteria commonly start
to colonize the gut. Furthermore, NEC has not been observed in
germfree animals [3] and infants with NEC frequently exhibit
concomitant bacteremia and endotoxemia.[4] Although various
microbes have been cultured from blood and stools in outbreaks of
NEC at single institutions, no single organism has consistently
been implicated across centers.[3] The human microbiome
project,[5] in conjunction with technologic advances that allow
for the molecular identification of a vast array of microbes that are
difficult or impossible to culture from the intestine,[6,7] has given
us new tools for generating evidence supporting the ‘‘abnormal
colonization hypothesis’’.[8] Studies have shown that multiple
environmental factors affect microbiota development,[9] and
others have suggested that modification of the microbiota may
confer clinical benefits.[10] Preliminary studies have evaluated
fecal microbiota from unaffected preterm infants and from infants
with NEC both prior to and during NEC.[11,12] These studies
suggest an association between the pattern of intestinal microbial
species and NEC.
In this study, we compared the intestinal microbiota in 9
premature infants with NEC to that of 9 matched and unaffected
control infants.
Materials and Methods
Patients
Preterm infants were enrolled from three University of Florida
affiliated hospitals. We studied infants with birth weights less than
or equal to 1,250 grams and gestational ages less than or equal to
32 completed weeks. Infants with known congenital malformations
of the intestine such as gastroschisis or atresias, and infants that
were not expected to survive beyond the first week, were excluded.
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20647All infants who met the inclusion criteria were enrolled in the
study shortly after birth. Informed written consent was obtained
from a parent by the attending physicians or research nurses at
each site. The study was approved by the Institutional Review
Boards at the University of Florida.
Nine of the approximately 200 babies enrolled in the study to
date met the criteria for diagnosis of NEC (Bell Stage 2 or 3 with
radiologic pneumatosis intestinalis and/or portal venous gas; or
direct intra-operative confirmation of intestinal pathology). [13,14]
Control infants were selected and matched to NEC case infants
using gestational age, birth weight, birth center, date of birth (+/2
2 months), and predominant enteral nutrient (breast milk vs..
formula).
Samples
Beginning with the first stool and continuing until discharge, we
collected weekly stool samples from study infants for immediate
storage at 280uC. The samples that were selected to be analyzed
from cases were those collected one week ‘‘prior’’ (median 7 days,
range 3–10 days) to the onset of NEC (and at equivalent time
points in controls), and those that were collected most ‘‘proximate’’
to the occurrence of NEC (all were within 72 hours of NEC onset).
Samples from control infants were chosen at the same week of life
at which the samples from the matched cases were obtained.
Microbiota Analysis
DNA extraction and quality control by denaturing
gradient gel electrophoresis (DGGE). DNA was extracted
from 200–300 mg fecal samples using a modified Qiagen stool
DNA extraction protocol that included a bead beating step.[15]
We used DGGE analysis of the V6–V8 region as described
previously,[12] for initial quality control.
16S rRNA sequence analysis. DNA was amplified using a
barcoded primer set based on universal primers 27F and 338R as
described by Hamady et al.[16] Cleaned PCR products were
pooled in equimolar amounts and submitted for sequencing using
454 Flex chemistry. From the resulting raw data set, low quality
sequences or sequences with a length less than 100 nucleotides
were removed. Sequences were initially analyzed using the
Ribosomal Database Project (RDP) pyrosequencing pipeline that
included features to calculate diversity indices and rarefaction
curves. We then used the ESPRIT algorithm [17] to bin sequences
into Operational Taxonomic Units (OTUs) using similarity levels
from 99% (species/strain level) to 80% (phylum level). We used
the QIIME package [18] to calculate i) Chao rarefaction diversity,
which estimates how many OUT’s are present in a sample, and ii)
UniFrac distances [19] , which allow for a comparison of the
distribution of OUT’s among samples.
Statistics
Student’s t-test was used when data were normally distributed;
otherwise a paired chi square test followed by Fisher combining
was used to test for a difference in the prevalence of OTUs. We
adjusted for an expected high false discovery rate by increasing the
requirement for statistical significance to p,0.01. The QIIME
package was used to calculate p-values for differences in UniFrac
distances.
Results
Patient Characteristics
The mean gestational age of all infants was 26.7 weeks (range,
23 to 30 weeks) and mean birth weight was 960 grams (range, 570
to 1,269 grams), There were 4 females and 5 males in the NEC
group and 5 females and 4 males in the control group (Table 1). In
each group, four infants were delivered by cesarean section. While
all of the cases received multiple antibiotics during the two weeks
prior NEC diagnosis, four of the five controls did not receive any
antibiotics at the matched period of life. There was no significant
differences in predominant diet (breast milk vs. formula) in the
infants with and without NEC prior to the development of the
disease.
Microbiota Analysis
After processing and screening of specimens, we analyzed a total
of 110,021 sequences that represented an average of 3,056
sequences per sample (range, 1,822–5,625). The average length
per sequence was 233 nucleotides (range, 100–292).
We then clustered sequences using ESPRIT at the 98%, 95%
and 90% similarity levels to obtain OTUs containing similar
sequences for further microbiota analysis. ESPRIT uses a novel
alignment algorithm that performs pairwise rather than multiple
sequence alignment. In its current implementation it has been
shown to improve alignment quality over other commonly used
algorithms that include CD-Hit and Uclust. Before removing
singletons (OTUs that contain only one sequence) we had 11510,
771 and 350 OTUs at the respective similarity levels. After
removal of singletons we retained 7768, 587 and 279 OTUs
respectively. To reduce loss of statistical power due to multiple
comparisons, we removed all OTUs with less than five sequences.
We retained 2636, 365 and 184 OTUs at the respective similarity
levels for analysis.
Using these binned sequence data, we first analyzed microbiota
structure and diversity with microbial ecology tools available in the
QIIME package. The total numbers of OUT’s present, as
estimated using Chao1-based rarefaction curves (a common
measure of diversity in populations) did not differ between cases
and controls at either of the two time points (Figure 1). When we
analyzed overall composition using the UniFrac metric (unweight-
ed), which is based on branch length differences between the case/
control groups in a phylogenetic tree generated from all 16S
rRNA sequences, we detected that one week before NEC
diagnosis seven out of the nine control samples clustered closely
together, whereas the nine NEC case samples were quite distant
from each other (Fig. 2A). We did not observe the same in the
samples collected during the week of NEC diagnosis (Fig. 2B).
Although diversity indices, which are calculated based on the
number and distribution of observed OUT’s, did not differ at
either time point, there was more variation in overall microbiota
structure in NEC infants one week before diagnosis whereas
microbiota was more similar in most controls.
We next analyzed differences in the proportion of bacterial
groups at the phylum level. Four phyla (Firmicutes, Proteobacteria,
Bacteroidetes and Actinobacteria) dominated the microbiota in most
samples (Figure 3). The proportion of Actinobacteria and Bacteroidetes
was lower in NEC than in control infants. We observed a 34%
increase in the proportion of Proteobacteria in NEC infants at the
expense of a 32% decrease in Firmicutes that occurred over the
week before the diagnosis of NEC. In contrast, the proportions of
the four major bacterial phyla in control infants did not change
significantly over the same time period. In NEC infants Firmicutes
dominated at the earlier time point. A late bloom of Palong with
continuously low numbers of Actinobacteria and Bacteroidetes was
observed in NEC infants during the week prior to diagnosis of
NEC.
Finally, as an exploratory analysis, we compared the distribution
of OTUs between the two groups at both time points. In the
hypervariable region of the 16S rRNA that we analyzed, a
Fecal Microbiota and NEC
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20647similarity level of 98% might equate to the level of strain, a
similarity level of 95% to the species level, and 90% similarity to
the genus level. At the 98% level, a variety of OTUs were more
frequently detected (p,0.01) in cases compared to controls
(Figure 4). In contrast to other microbiota studies in older children
and adults where most of the ‘unknown’ OTUs group to the
phylum Firmicutes or Bacteroidetes, we detected a particular
‘unknown’ OTU that grouped to the c-Proteobacteria. This OTU
was detected in 3/9 NEC cases but in none of the controls
(p,0.01). This OTU appears most closely related to the
Enterobacteriaceae, a family that contains many known pathogens
and accordingly has been extensively studied. Surprisingly,
although the OTU matched this well-studied family, no strains
in the database achieved more than a 97% match. In addition to
this ‘unknown’ OUT’ we detected a variety of other OTUs at the
time of diagnosis that were found only in NEC infants. These
OTUs grouped closest to known Enterobacteriaceae (Cronobacter
muytjensii, Escherichia coli, Enterobacter sp.; Klebsiella pneumoniae) and
to Staphylococcus epidermidis.
Discussion
The healthy adult human harbors roughly 1610
14 bacteria in
the intestinal tract and these organisms make up about 60% of the
Table 1. Characteristics of study subjects.
Patient ID Gender GAge Weight Delivery Diet Antibiotics Fed Stage DoL NEC
Case 1 F 29 1020 CS BM G,O 1 2 5
Case 2 F 27 1080 SVD Both G,M,O 1 2 15
Case 3 M 25 1052 CS BM A,G,O 1 2 25
Case 4 M 25 570 SVD Form A,G,N,V,Z 6 3 24
Case 5 M 26 967 CS BM A,G,N,V 1 3 28
Case 6a M 23 639 SVD BM E,V,G 5 3 11
Case 6b F 28 1225 SVD Form A,G,Z 1 2 5
Case 7 F 27 920 SVD BM A,T 2 2 39
Case 8 F 26 750 CS Both G,V,Z 6 3 20
Case 9 M 24 734 SVD BM G,V,Z 3 3 41
Control 1 M 28 1102 SVD BM V 2 X X
Control 2 M 28 1140 CS BM None 5 X X
Control 3 F 27 875 SVD BM C,G 1 X X
Control 4 F 26 652 SVD Both None 2 X X
Control 5 M 26 1020 CS BM A,C,E 11 X X
Control 6 M 28 1269 CS BM A,G 1 X X
Control 7 F 30 1263 CS BM None 1 X X
Control 8 F 28 1115 SVD BM G,N,V 1 X X
Control 9 F 27 1120 SVD Both None 1 X X
GAge: Gestational age in weeks, Weight: weight at birth in g, Delivery: CS: Caesarian, SVD: Spontaneous Vaginal Delivery, Diet: BM: Breast Milk, Form: Formula, Both:
Breast Milk and Formula, O: Oxacillin, G: Gentamicin, M: Meropenem, E: Erythromycin, N: Nafcillin, C: Ceftazidime, T:Tobramycin, Z: Zosyn, Am: Ampicillin, Az:
Azithromycin, Fed: day of life at first meal, Stage: Bell’s stage, DoL NEC: day of life NEC diagnosed, Case 6a indicates patient before and case 6b patient at diagnosis.
doi:10.1371/journal.pone.0020647.t001
Figure 1. Chao rarefaction diversity. Chao diversity was calculated from sequence distribution A) one week before and B) within 72 hours of NEC
diagnosis.
doi:10.1371/journal.pone.0020647.g001
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bacteria can affect health and influence disease states. While
human data are just starting to emerge, animal studies have
suggested that microbiota composition in the neonatal period may
affect gastrointestinal (GI) tract development, mucosal integrity,
and even nutritional status.[21,22] Thus, developing an under-
standing of the neonatal (especially the very preterm) microbiota
would be invaluable in helping to elucidate the processes that
promote health or alternatively predispose to diseases, such as
NEC.
Figure 2. Unifrac diversity measures. Principal component analysis (PCA) of overall diversity based on UniFrac (unweighted) metric A) one week
before and B) within 72 hours of NEC diagnosis. Squares represent controls and circles represent cases. P1 is component 1 and P2 component 2.
doi:10.1371/journal.pone.0020647.g002
Figure 3. Changes in proportion of bacterial phyla. Proportions of the four major phyla in nine controls and nine cases one week before and
within 72 hours of NEC diagnosis.
doi:10.1371/journal.pone.0020647.g003
Fecal Microbiota and NEC
PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e20647Fecal Microbiota and NEC
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microbiota diversity in samples collected from cases after NEC
diagnosis and a distinct clustering when compared with matched
controls,[11] we did not detect such differences in overall diversity
measures in our study. Rather, our findings confirm and extend
our earlier observation that overall microbiota diversity at the time
of diagnosis does not differ between healthy preterm infants and
infants with NEC.[23] Our observation that one week before
diagnosis microbial structure was more heterogeneous in infants
that developed NEC suggests the potential for early detection of
risk and focused intervention. Based on the data presented here it
is feasible that future studies that include more cases will allow for
the identification of a ‘‘high risk’’ microbiota pattern based on
discriminant analysis of 16S rRNA sequences.[24]
We used high throughput sequencing in a prospective study
design. Our sequence depth per subject was more than 20 times
deeper than that previously reported [11] allowing us to detect
rare OTUs that would have been missed with less extensive
sequencing. We did confirm the presence of a higher proportion of
Proteobacteria that the same group reported only after the diagnosis
of NEC. [11] Furthermore, we observed that the proportion of
Proteobacteria increased in samples collected from NEC infants over
the week prior to the diagnosis of NEC. In the samples collected
from the NEC infants one week before diagnosis, the proportion of
Proteobacteria was actually lower than that observed in the matched
control samples. Hence, our data raise the possibility that preterm
infants not sufficiently colonized with Proteobacteria during the first
weeks of life during which early immune protection or tolerance
might develop, may not be able to modulate an adaptive
immunological response to a subsequent bloom of Proteobacteria,
and instead develop intestinal pathology consistent with NEC.
A recently published study[25] reported that, using similar
sequencing techniques, less than 10% of healthy infants carried
Enterobacteria until the sixth week of life when a bloom occurred.
Our study went further as we detected specific OTUs that
increased in NEC infants during the week prior to diagnosis. Most
of these OTUs grouped to the Enterobacteriaceae, and represented
both known and unknown species. An OTU matching S.
epidermidis, a common skin commensal, was also exclusively
detected in infants with NEC.
We could not confirm a report by others that suggested a
contribution of clostridia species and their toxins to NEC.[26] We
did not observe an association of NEC risk with the presence of
Citrobacter like sequences or the frequency of Enterococcusas
suggested in preliminary studies.[12] However, in the current
study we have sufficient power for detecting differences between
groups in any OUT’s that contributed at least 0.5% to the overall
microbiota in the majority of samples from cases or controls.
Our observations regarding any of the OUT’s that were more
frequently detected in cases should be interpreted with caution.
We initially compared distributions of more than a thousand
OUT’s. Even after removal of rare OUT’s we retained many
hundreds of OUT’s in our analysis. Due to the exploratory
character of our study we did not correct for multiple analyses,
although we did lower the significance level to p,0.01. Thus, we
cannot exclude the possibility that some of our findings did occur
by chance. Furthermore, as we studied microbiota development
only in preterm infants born in Florida, our findings cannot
necessarily be generalized to other populations.
Among the many OTUs that we evaluated we did detect an
increase in the numbers of a particular OTU that matched closest
to the Enterobacteriaceae. When we searched Genbank for the closest
match using a blast search, we did not detect any sequence that
matched this OTU by more than 97%. This is an intriguing
observation because the Enterobacteriaceae family is particularly well-
studied and contains many established enteric pathogens that
harbor a variety of known virulence factors. Our finding is
consistent with the hypothesis that a novel pathogen might be an
important etiologic factor in at least a subset of infants with NEC.
One line of evidence that provides support for the notion that this
organism belongs to a class of microbes that has special pathogenic
characteristics involves the lipid A moiety of the cell wall LPS,
which is known to differ between organisms. Animals use the
TLR4 receptor mechanism to recognize the lipid A moiety of LPS.
LPS recognition and pro-inflammatory signaling by TLR4 occurs
only when lipid A has a certain structure; it contains both
phosphates and is a hexaacyl.[27] In the Bacteroidetes that
sometimes dominate the gut microbiota in adults, the LPS is
pentacylated, making it a less efficient activator of the TLR4
mechanism leading to decreased immunogenicity.[28] However in
Proteobacteria, the lipid A is hexacylated, making it a potent agonist
for the TLR4 system and thus more immunogenic. During times
of health, the immunogenic properties of the LPS of Proteobacteria
are muted by the overwhelming predominance of Bacteroidetes and
Firmicutes. However, during inflammation (as occurs in diseases
such as NEC), there is a relative decrease in the presence of these
less immunogenic bacteria and a relative increase in Proteobacteria,
as shown by our results.
In addition to specific OTUs that appeared to be associated
with NEC we also detected a bloom in Proteobacteria unique to the
NEC infants. Our observations require confirmation in further
studies and with different methodologies. Such studies are
currently ongoing at our institution and elsewhere as part of the
Human Microbiome Project. We are hopeful that a better
understanding of NEC etiology from such studies might be rapidly
translated into better diagnostic tools and prophylactic interven-
tions that will meaningfully reduce the incidence and severity of
NEC in preterm infants.
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Staphylococcus epidermidis.
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